Single-Dose Psoriasis Research Study

This study will evaluate the safety and tolerability of an investigational medication for psoriasis.

Study participants must be generally healthy and at least 18 years of age with mild to moderate plaque-type psoriasis for at least 6 months. 

Study participants will receive one dose of study medication, and will then be asked to return to the study clinic multiple times for approximately 8 weeks for safety monitoring.

This study will involve 10 to 12 visits to the study clinic. There is no cost to participate and compensation for the time and travel associated with the study is available. 

This study is being conducted by Dermatologists that specialize in the assessment and treatment of psoriasis.

For more information please contact the Dermatology clinic near you or register now.

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more